Ph II CABOGIST in GIST

NCT02216578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Gastrointestinal Stromal Tumor

Interventions

DRUG: cabozantinib

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC